Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Teng

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
Current Cancer Drug Targets|March 21, 2018
Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer ProgressionLiwei Lang, Austin Y Shull, Yong Teng
Cells|March 20, 2019
Drugging the Small GTPase Pathways in Cancer Treatment: Promises and ChallengesNéstor Prieto-Dominguez, Christopher Parnell, Yong Teng
Genes, Chromosomes & Cancer|February 25, 2017
Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter geneYong Teng, Lambert Ngoka, John K Cowell
Future Medicinal Chemistry|November 29, 2017
Friend or foe? Mitochondria as a pharmacological target in cancer treatmentTyler Dickerson, Catherine E Jauregui, Yong Teng
Future Medicinal Chemistry|February 9, 2017
Targeting autophagy as a strategy for drug discovery and therapeutic modulationLixia Gao, Catherine E Jauregui, Yong Teng
International Journal of Cancer|May 6, 2011
Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cellsYong Teng, Mingyao Liu, John K Cowell
Current Cancer Drug Targets|May 23, 2017
The Complexity of DEK Signaling in Cancer ProgressionYong Teng, Liwei Lang, Catherine E Jauregui
Environmental Science and Pollution Research International|February 21, 2015
Assessment of soil organic contamination in a typical petrochemical industry park in ChinaYong Teng, Qixing Zhou, Xinyu Miao, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2017
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeuticsLiwei Lang, Chloe Shay, Xiangdong Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2026
Glycolytic cancer-associated fibroblasts orchestrate metabolic remodeling in the tumor microenvironmentXinyu Cui, Akshaya Poonepalle, Chloe Shay, et al.
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
Current Cancer Drug Targets|March 21, 2018
Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer ProgressionLiwei Lang, Austin Y Shull, Yong Teng
Cells|March 20, 2019
Drugging the Small GTPase Pathways in Cancer Treatment: Promises and ChallengesNéstor Prieto-Dominguez, Christopher Parnell, Yong Teng
Genes, Chromosomes & Cancer|February 25, 2017
Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter geneYong Teng, Lambert Ngoka, John K Cowell
Future Medicinal Chemistry|November 29, 2017
Friend or foe? Mitochondria as a pharmacological target in cancer treatmentTyler Dickerson, Catherine E Jauregui, Yong Teng
Future Medicinal Chemistry|February 9, 2017
Targeting autophagy as a strategy for drug discovery and therapeutic modulationLixia Gao, Catherine E Jauregui, Yong Teng
International Journal of Cancer|May 6, 2011
Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cellsYong Teng, Mingyao Liu, John K Cowell
Current Cancer Drug Targets|May 23, 2017
The Complexity of DEK Signaling in Cancer ProgressionYong Teng, Liwei Lang, Catherine E Jauregui
Environmental Science and Pollution Research International|February 21, 2015
Assessment of soil organic contamination in a typical petrochemical industry park in ChinaYong Teng, Qixing Zhou, Xinyu Miao, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2017
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeuticsLiwei Lang, Chloe Shay, Xiangdong Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2026
Glycolytic cancer-associated fibroblasts orchestrate metabolic remodeling in the tumor microenvironmentXinyu Cui, Akshaya Poonepalle, Chloe Shay, et al.
Pageof 24